Alamar Biosciences Inc. (ALMR)
ALMR trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$23.52
-2.97% on the day
Market cap
$1.6B
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ALMR on Nasdaq |
| Sector | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0002104204 |
| SEC industry code | Laboratory Analytical Instruments |
| Incorporated in | DE |
Financials
New registrant: no annual report filed under this company yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2026-04-20 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-09-01 |
Source: SEC EDGAR submissions feed, 50 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -8.8% |
| 1 month | -11.9% |
| 3 months | +1.5% |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -33.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Laboratory Analytical Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CTKB | Cytek Biosciences Inc. | $5.35 | +0.75% | $695.4M |
| PACB | Pacific Biosciences of California Inc. | $2.05 | -2.38% | $637.2M |
| BRKR | Bruker Corporation | $56.19 | -0.11% | $8.6B |
| TXG | 10x Genomics Inc. | $71.79 | -4.52% | $9.4B |
| BIO | Bio-Rad Laboratories Inc. | $363.73 | -0.19% | $9.7B |
| EYPT | EyePoint Inc. | $3.07 | -7.53% | $264.7M |
| NAUT | Nautilus Biotechnology Inc. | $2.05 | -5.53% | $260.9M |
| LAB | Standard BioTools Inc. | $0.6589 | +0.17% | $260.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier